Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Zapardiel I, Gracia Segovia M, Macuks R, Mancari R, Achimas-Cadariu P, Corrado G, Bartusevicius A, Sukhin V, Muruzabal JC, Coronado Martín PJ, Gardella B, Piek JM, Concin N, Arab C, Papatheodorou D, Polterauer S, Iacoponi S, Nieto T, Lopez-Sanclemente MC, Trukhan H, Gil MM, Bakinovskaya I, Dalamanava A, Cucurull M, Rovski D, Baquedano L, Chiva L, Mardas M, Mavrichev SA, Klat J, Lopez de la Manzanara CA, Yildirim Y; SARCUT Study Group. Zapardiel I, et al. Among authors: mancari r. Int J Gynecol Cancer. 2023 Jun 5;33(6):897-904. doi: 10.1136/ijgc-2022-004204. Int J Gynecol Cancer. 2023. PMID: 37192761
Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival.
Gracia M, Yildirim Y, Macuks R, Mancari R, Achimas-Cadariu P, Polterauer S, Iacoponi S, Zapardiel I; SARCUT Study Group. Gracia M, et al. Among authors: mancari r. Cancers (Basel). 2023 Feb 25;15(5):1463. doi: 10.3390/cancers15051463. Cancers (Basel). 2023. PMID: 36900255 Free PMC article.
Lymph node dissection in uterine leiomyosarcomas: A matched-pair study.
Coronado PJ, Alonso-Espias M, Yildirim Y, Macuks R, Mancari R, Achimas-Cadariu P, Aniorte SM, Mitidieri M, Lambaudie E, Dubois N, Zapardiel I; SARCUT Study Group. Coronado PJ, et al. Among authors: mancari r. Gynecol Oncol. 2023 Jul;174:28-33. doi: 10.1016/j.ygyno.2023.04.007. Epub 2023 May 3. Gynecol Oncol. 2023. PMID: 37146437
Impact of Hospital Case Volume on Uterine Sarcoma Prognosis: SARCUT Study Subanalysis.
Gorostidi M, Yildirim Y, Macuks R, Mancari R, Achimas-Cadariu P, Ibañez E, Corrado G, Bartusevicius A, Sukhina O, Zapardiel I; SARCUT Study Group. Gorostidi M, et al. Among authors: mancari r. Ann Surg Oncol. 2023 Nov;30(12):7645-7652. doi: 10.1245/s10434-023-13826-4. Epub 2023 Jul 17. Ann Surg Oncol. 2023. PMID: 37460742
[No title available]
[No authors listed] [No authors listed] PMID: 37648890
Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
Bizzarri N, Imterat M, Fruscio R, Giannarelli D, Perrone AM, Mancari R, Traut A, Rosati A, du Bois A, Ferrari D, De Iaco P, Ergasti R, Ataseven B, Bianchi T, Di Stanislao M, Perri MT, Heitz F, Concin N, Fanfani F, Vizza E, Scambia G, Harter P, Fagotti A. Bizzarri N, et al. Among authors: mancari r. Eur J Cancer. 2023 Dec;195:113398. doi: 10.1016/j.ejca.2023.113398. Epub 2023 Oct 20. Eur J Cancer. 2023. PMID: 37890354 Free article.
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer.
Colombo N, Tomao F, Benedetti Panici P, Nicoletto MO, Tognon G, Bologna A, Lissoni AA, DeCensi A, Lapresa M, Mancari R, Palaia I, Tasca G, Tettamanzi F, Alvisi MF, Rulli E, Poli D, Carlucci L, Torri V, Fossati R, Biagioli E; BAROCCO study group. Colombo N, et al. Among authors: mancari r. Gynecol Oncol. 2022 Mar;164(3):505-513. doi: 10.1016/j.ygyno.2022.01.015. Epub 2022 Jan 19. Gynecol Oncol. 2022. PMID: 35063281 Clinical Trial.
37 results